StockViz
RANKINGS
Yixintang Pharmaceutical Group Co., Ltd.
Shenzhen Stock Exchange:002727.SZ
Sector
Location
Market Cap
USD 1.35 B
Share Price
USD 2.28
Avg Daily Volume
17,133,408
Change (1 day)
-0.88%
Change (1 year)
13.19%
Change (YTD)
28.09%
Yixintang Pharmaceutical Group Co., Ltd. Income Statement 2014 - 2024
This table shows the Income Statement for Yixintang Pharmaceutical Group Co., Ltd. going from 2014 until 2024. The income statement, also known as the profit and loss statement, is a financial statement that provides a summary of a company's revenues, expenses, and net income over a specific period (such as a quarter or a year). It shows the company's ability to generate revenue, manage expenses, and ultimately determine its profitability.
Income Statement
| Annual data in millions of USD, except per share data | Trend |
|---|
Competitors
Johnson & Johnson
USD 156.01
JNJ
+0.45
0.29%
Wal-Mart de México, S.A.B. de C.V.
USD 3.27
WALMEX.MX
-0.07
-2.03%
Loblaw Companies Limited
USD 164.13
L.TO
+2.22
1.37%
George Weston Limited
USD 198.86
WN.TO
+3.23
1.65%
Zhangzhou Pientzehuang Pharmaceutical., Ltd
USD 27.72
600436.SS
-0.04
-0.13%
Metro Inc.
USD 77.45
MRU.TO
+1.39
1.83%
Yunnan Baiyao Group Co.,Ltd
USD 7.76
000538.SZ
-0.02
-0.31%
Albertsons Companies, Inc.
USD 21.93
ACI
-0.06
-0.27%
AptarGroup, Inc.
USD 161.04
ATR
+0.72
0.45%
Walgreens Boots Alliance, Inc.
USD 11.45
WBA
-0.04
-0.35%
Huadong Medicine Co., Ltd
USD 5.69
000963.SZ
+0.06
1.07%
President Chain Store Corporation
USD 9.18
2912.TW
+0.11
1.26%
Alibaba Health Information Technology Limited
USD 0.54
0241.HK
-0.04
-6.63%
Shoprite Holdings Limited
USD 16.20
SHP.JO
+0.46
2.95%
Ypsomed Holding AG
USD 523.38
YPSN.SW
-0.91
-0.17%
Reece Limited
USD 9.72
REH.AX
+0.36
3.81%
Hikma Pharmaceuticals PLC
USD 27.12
HIK.L
+0.12
0.45%
PT Sumber Alfaria Trijaya Tbk
USD 0.15
AMRT.JK
-0.00
-1.97%
Guangzhou Baiyunshan Pharmaceutical Holdings Company Limited
USD 2.25
0874.HK
+0.01
0.35%
Galenica AG
USD 110.69
GALE.SW
+0.17
0.15%